FULGENT GENETICS, INC. Capital Expenditures
FULGENT GENETICS, INC. (FLGT) reported Capital Expenditures of $9.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-30
- FULGENT GENETICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $3.86M, a 43.48% decline year-over-year.
- FULGENT GENETICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $5.20M, a 10.26% increase year-over-year.
- FULGENT GENETICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $4.98M, a 31.82% increase year-over-year.
- FULGENT GENETICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $6.05M, a 69.03% decline year-over-year.
- FULGENT GENETICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $22.57M, a 44.01% decline from fiscal 2024.
- FULGENT GENETICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $40.31M, a 81.54% increase from fiscal 2023.
- FULGENT GENETICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $22.21M, a 18.28% increase from fiscal 2022.
- FULGENT GENETICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $18.77M, a 21.15% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $9.06M 10-Q · filed 2026-07-30 | $14.04M derived: sum of 3 quarters · filed 2026-07-30 | $20.09M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $5.20M 10-Q · filed 2026-05-01 | $10.18M derived: sum of 2 quarters · filed 2026-05-01 | $16.23M derived: sum of 3 quarters · filed 2026-05-01 | $23.06M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $11.03M derived: sum of 2 quarters · filed 2026-02-27 | $17.86M derived: sum of 3 quarters · filed 2026-07-30 | $22.57M 10-K · filed 2026-02-27 |
| 2025-09-30 | $6.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $12.88M derived: sum of 2 quarters · filed 2026-07-30 | $17.59M 10-Q · filed 2025-11-07 | $21.37M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $6.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $11.54M 10-Q · filed 2026-07-30 | $15.32M derived: sum of 3 quarters · filed 2026-07-30 | $34.86M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $4.72M 10-Q · filed 2026-05-01 | $8.50M derived: sum of 2 quarters · filed 2026-05-01 | $28.03M derived: sum of 3 quarters · filed 2026-05-01 | $40.98M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $23.32M derived: sum of 2 quarters · filed 2026-02-27 | $36.26M derived: sum of 3 quarters · filed 2026-02-27 | $40.31M 10-K · filed 2026-02-27 |
| 2024-09-30 | $19.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $32.48M derived: sum of 2 quarters · filed 2025-11-07 | $36.54M 10-Q · filed 2025-11-07 | $39.64M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $12.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $17.00M 10-Q · filed 2025-08-01 | $20.11M derived: sum of 3 quarters · filed 2026-02-27 | $25.03M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $4.06M 10-Q · filed 2025-05-02 | $7.16M derived: sum of 2 quarters · filed 2026-02-27 | $12.09M derived: sum of 3 quarters · filed 2026-02-27 | $24.23M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $8.03M derived: sum of 2 quarters · filed 2026-02-27 | $20.17M derived: sum of 3 quarters · filed 2026-02-27 | $22.21M 10-K · filed 2026-02-27 |
| 2023-09-30 | $4.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $17.07M derived: sum of 2 quarters · filed 2024-11-08 | $19.10M 10-Q · filed 2024-11-08 | $23.82M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $12.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $14.18M 10-Q · filed 2024-08-02 | $18.90M derived: sum of 3 quarters · filed 2025-02-28 | $24.34M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $2.03M 10-Q · filed 2024-05-03 | $6.76M derived: sum of 2 quarters · filed 2025-02-28 | $12.19M derived: sum of 3 quarters · filed 2025-02-28 | $15.45M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $10.16M derived: sum of 2 quarters · filed 2025-02-28 | $13.41M derived: sum of 3 quarters · filed 2025-02-28 | $18.77M 10-K · filed 2025-02-28 |
| 2022-09-30 | $5.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $8.69M derived: sum of 2 quarters · filed 2023-11-03 | $14.05M 10-Q · filed 2023-11-03 | $20.04M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $8.62M 10-Q · filed 2023-08-04 | $14.60M derived: sum of 3 quarters · filed 2024-02-28 | $18.00M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $5.36M 10-Q · filed 2023-05-05 | $11.34M derived: sum of 2 quarters · filed 2024-02-28 | $14.74M derived: sum of 3 quarters · filed 2024-02-28 | $17.68M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $5.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $9.38M derived: sum of 2 quarters · filed 2024-02-28 | $12.32M derived: sum of 3 quarters · filed 2024-02-28 | $23.81M 10-K · filed 2024-02-28 |
| 2021-09-30 | $3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $6.34M derived: sum of 2 quarters · filed 2022-11-07 | $17.83M 10-Q · filed 2022-11-07 | $41.62M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $14.43M 10-Q · filed 2022-08-04 | $38.22M derived: sum of 3 quarters · filed 2023-02-28 | $48.35M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $11.49M 10-Q · filed 2022-05-05 | $35.29M derived: sum of 2 quarters · filed 2023-02-28 | $45.41M derived: sum of 3 quarters · filed 2023-02-28 | $45.83M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $23.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $33.92M derived: sum of 2 quarters · filed 2023-02-28 | $34.33M derived: sum of 3 quarters · filed 2023-02-28 | $35.13M 10-K · filed 2023-02-28 |
| 2020-09-30 | $10.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $10.54M derived: sum of 2 quarters · filed 2021-11-09 | $11.34M 10-Q · filed 2021-11-09 | $11.80M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $411.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $1.21M 10-Q · filed 2021-08-10 | $1.67M derived: sum of 3 quarters · filed 2022-02-28 | $1.76M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $796.00K 10-Q · filed 2021-05-07 | $1.26M derived: sum of 2 quarters · filed 2022-02-28 | $1.34M derived: sum of 3 quarters · filed 2022-02-28 | $1.84M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $461.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $549.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.05M derived: sum of 3 quarters · filed 2022-02-28 | $1.18M 10-K · filed 2022-02-28 |
| 2019-09-30 | $88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $587.00K derived: sum of 2 quarters · filed 2020-11-09 | $721.00K 10-Q · filed 2020-11-09 | $844.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $499.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $633.00K 10-Q · filed 2020-08-05 | $756.00K derived: sum of 3 quarters · filed 2020-08-05 | $1.80M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $134.00K 10-Q · filed 2020-05-06 | $257.00K derived: sum of 2 quarters · filed 2020-05-06 | $1.30M derived: sum of 3 quarters · filed 2020-05-06 | $1.34M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $1.17M derived: sum of 2 quarters · filed 2020-03-13 | $1.21M derived: sum of 3 quarters · filed 2020-03-13 | $2.32M 10-K · filed 2020-03-13 |
| 2018-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.08M derived: sum of 2 quarters · filed 2019-11-08 | $2.20M 10-Q · filed 2019-11-08 | $3.34M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $1.15M 10-Q · filed 2019-08-12 | $2.29M derived: sum of 3 quarters · filed 2019-08-12 | $2.53M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $1.12M 10-Q · filed 2019-05-10 | $2.26M derived: sum of 2 quarters · filed 2019-05-10 | $2.49M derived: sum of 3 quarters · filed 2019-05-10 | $3.92M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $1.38M derived: sum of 2 quarters · filed 2019-03-22 | $2.81M derived: sum of 3 quarters · filed 2019-03-22 | $2.90M 10-K · filed 2019-03-22 |
| 2017-09-30 | $237.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.66M derived: sum of 2 quarters · filed 2018-11-09 | $1.75M 10-Q · filed 2018-11-09 | $2.16M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $1.52M 10-Q · filed 2018-08-13 | $1.93M derived: sum of 3 quarters · filed 2018-08-13 | $4.74M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $90.00K 10-Q · filed 2018-05-14 | $499.00K derived: sum of 2 quarters · filed 2018-05-14 | $3.31M derived: sum of 3 quarters · filed 2018-05-14 | $3.70M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $3.23M derived: sum of 2 quarters · filed 2018-03-20 | $3.61M derived: sum of 3 quarters · filed 2018-03-20 | $3.79M 10-K · filed 2018-03-20 |
| 2016-09-30 | $2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $3.20M derived: sum of 2 quarters · filed 2017-11-13 | $3.38M 10-Q · filed 2017-11-13 | $3.60M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $563.00K 10-Q · filed 2017-08-14 | $788.00K derived: sum of 3 quarters · filed 2017-08-14 | |
| 2016-03-31 | $177.00K 10-Q · filed 2017-05-09 | $402.00K derived: sum of 2 quarters · filed 2017-05-09 | ||
| 2015-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $2.10M 10-K · filed 2017-03-17 | ||
| 2015-09-30 | $1.88M 10-Q · filed 2016-11-14 | |||
| 2014-12-31 | $731.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |